AHPBA Research Development Grant
The purpose of this award is to provide the opportunity for Junior faculty to perform research during the 2022 – 2023 academic year. Junior Faculty is defined as less than 7 years from fellowship training graduation (e.g. completed fellowship training no sooner than August 1, 2014). Exceptions to time from training and meeting attendance will be considered for leaves of absence during initial faculty appointment including but not limited to personal or family illness, military deployment, maternity leave, or others considered on a case-by-case basis. The research can be clinical, outcomes, translational, or basic science, but must focus on the liver, pancreas, or biliary system. Applicants must have a minimum of 20% protected time verified by dept chair to conduct said research, and the project must be feasible to complete within the one-year award time frame. The amount of the award is $30,000.
Deadline: Monday, November 1, 2021 at 11:59pm EDT
2021
Jonathan Sham MD
University of Washington
Novel Drug-eluting Biopolymer Reduce Pancreatic Fistula After Pancreatic Surgery
2020
Rory Smoot MD, MSE
Mayo Clinic
Nanovesicle-mediated Targeting of YAP Activation in Cholangiocarcinoma to Enhance Chemotherapy Sensitivity
2019
Joshua Leinwand MD, MSE
NYU Langone
The Microbiome and Regulation of Hepatic Immunity
Lawrence Delrosario MD
University of Michigan
Diabetes-Mediated Enhancement of Pancreatic Tumorigenesis: Exploring The Role of Adipocyte-Cancer Crosstalk
2018
Bradley A. Krasnick MD
Washington University/ Barnes Jewish Hospital
A Humanized Mouse Model of Pancreatic Ductal Adenocarcinoma
Mohammad Raheel Jajja MD
Emory University
Peptide Nanoprobes For Multi-Receptor-Targeting and Optical Imaging of Colorectal Liver Metastases
2017
Alexander Gaidarski, MD
University of Miami Miller School of Medicine
Role of p16 in Sensitivity to MEK Inhibition in Pancreatic Cancer
Georgios Gemenetzis, MD
Johns Hopkins University School of Medicine
Circulating tumor cells in pancreatic adenocarcinoma: effect of cancer-directed therapy and ex vivo modeling
2016
Derek J. Erstad, MD
Massachusetts General Hospital
Molecular MR imaging of Desmoplasia after Neoadjuvannt Treatment of Pancreatic Cancer
Nicholas G. Berger, MD
Medical College of Wisconsin
Determination of Xanthohumol inhibits Notch signaling in vivo and increases the survival and reduces tumor progression in HCC liver xenograft
2015
Samer Tohme, MD
University of Pittsburgh
The Role of Neutrophil Extracellular Traps in Liver Sterile Inflammation
Supported By: AHPB Foundation
Ashton Connor, MD
University of Toronto
Genomic and Transcriptomic Characterization of Pancreatic Cancer
Supported By: AHPBA
2014
Jonathan Hernandez, MD
Memorial Sloan-Kettering Cancer Center
Characterization of Dormancy and Outgrowth for Metastatic Pancreatic Cancer in the Liver
Supported By: AHPBA
2013
Physiology/Biology Research Grant
Stephanie Greco, MD
New York University School of Medicine - Department of Surgery
Regulation of Acute Pancreatitis by C-type Lectin Receptors
Supported By: AHPBA
2012
Oncology Research Grant
Kevin Soares, MD
Johns Hopkins Hospital Surgery
Combinatorial Immunotherapy and the Manipulation of Tumor Microenvironment in the Treatment of Pancreatic Cancer
Supported By: AHPBA
2011
Oncology Research Grant
Michele Babicky, MD
University of California, San Diego Medical Center
Targeting the RON Tyrosine Kinase Receptor in Pancreatic Cancer
Supported By: AHPBA
2008
Surgical Technology Assessment and Outcomes Research Grant
Peter Nau, MD
The Ohio State University Medical Center Center for Minimally Invasive Surgery
Development of a Novel Repair Technique for latrogenic Common Bile Duct Injuries with a Biosynthetic Absorbable Graft
Supported By: Covidien and AHPBA
Physiology/Biology Research Grant
Kendra D. Conzen. MD
Washington University
The Role of HMGB1 in Steatotic Livers following Ischemia/Reperfusion
Supported By: Ethicon, Inc. and AHPBA
Oncology Research Grant
Wigdan Al-Sukhni
University of Toronto
An analysis of germline genomic copy-number variation to identify disease-associated gene(s) in familial pancreatic cancer
Supported By: Sanofi Aventis and AHPBA
2007
Covidien Surgical Technology Assessment
Lia Roque Assumpcao, MD
Johns Hopkins University Hospital
Application of Novel, High Resolution, and Freehand Ultrasound Elasticity Imaging in Liver Surgery
Sanofi-anventis HPB Oncology
Bedabrata Sarkar, MD
University of Michigan Medical School
Characterization of Pancreatic Cancer Stem Cells
Ethicon HPB Physiology/Biology
Lee Ocuin, MD
Memorial Sloan-Kettering Cancer Center
Immune Activation of Human Liver Dendritic Cells
2006
Ethicon HPB Physiology/Biology
Luis Garcia, MD
The Milton S. Hershey Medical Center
Targeted Inhibition of VEGF Prevents Development of Tumor Antigen-Specific T-Cell Tolerance in the Murine Liver
Sanofi-aventis HPB Oncology
Jon Cardinal, MD
University of Pittsburgh
Crossroad in Cancer Signaling: Regulation of Human iNOS Expression by the WNT B-Catenin Path
2005
Ethicon HPB Physiology/Biology
Sunil K. Geevarghese, MD
Vanderbilt University Medical Center
The Role of Mitochondrial Calcium Management in Hepatic Ischemia-Reperfusion Injury following Syngeneic Rat Liver Transplantation
Sanofi-aventis HPB Oncology
Jon Dorfman, MD
Massachusetts General Hospital
Positron Emission Tomography to Monitor HSV-2 Viral Oncolysis
2004
Ethicon HPB
Jennifer Lynn Irani, MD
Brigham and Women's Hospital
The Role of CEACAM6 in Pancreatic Cancer Invasion
2003
Ethicon HPB
Shiva Sarraf-Yazdi, MD
Duke University Medical Center
Anti-angiogenic Therapy of Murine Liver Metastases by Tie2 Inhibition
2002
Ethicon HPB
Charles M. Vollmer, MD
University of Toronto
Characterization of a Novel Translocation Breakpoint in Pancreatic Cancer
2001
Ethicon HPB
Nicole Chandler, MD
Beth Israel Deaconess Medical Center
Overcoming Chemoresistance in Human Pancreatic Cancer